LONG TERM INVESTMENT
Who told people to buy KIDE when it was $10?
GUMM is my next pick. A few of us bought KIDE
(Eric, Bo, Dr. Epstein). A lot more wished they
had bought and HELD.
Here is a review of GumTech for new readers:
Gum Tech International (Nasdaq: GUMM)
The Company develops and manufactures specialty chewing gum products for branded and private label customers, as well as products marketed under the Gum Tech brand. The products contain vitamins, herbals and/or active drug ingredients. Gum Tech currently targets four market segments: oral care, smoking cessation, dietary supplement, and over-the-counter (OTC) drug.
5.6 million Float
But it will behave like it has 1.6 million float (the effective float) because ~4 million of the float is held by long term holders who have extremely high price targets in the long term and have no plans to sell. This same factor attributed to KIDE's success as an investment.
Each time the float is recycled the support level rises. As the effective float is recycled there will be shareholders who will simply not sell. Which means the effective float decreases while demand increases.
GumTech has two markets:
1. Functional Chewing Gum
2. Newly introduced Common Cold Remedy - Zicam.
Developing a generic Nicorrette Chewing Gum has become
a high priority. Here are the numbers SBH is racking up
on their product:
biz.yahoo.com
SMITHKLINE BEECHAM
>>SB's smoking cessation franchise delivered another outstanding
performance, growing 68 percent to $183 million /112 million pounds.Sales of Nicorette, the smoking cessation gum, increased 92 percent, helped by the launch of the new mint flavor, while sales of NicoDerm CQ, the smoking cessation patch, increased 23 percent.<<
** Now for the biggee! Zicam - the very best common cold remedy.
COMMON COLD -- ZICAM - zicam.com 60% owned by GUMM
- Over 1 BILLION common Colds in the US per year
- 5.5 BILLION is spent on colds in the US with about
$2.3 BILLION spent on cold remedies.
What Cold remedy is the best? With no hesitation, its ZICAM
zicam.com
Because it is the most effective cold remedy, its the one people will buy. ZICAM will claim a growing chunk of the $2.3 Billion spent on remedies year after year.....think long term. GUMM is an IRA type, long term investment you will not want to sell.
COMMON COLD MARKET FIGURES:
Message 10790871
PHARMACEUTICAL Wholesaler's Point of View:
post.messages.yahoo.com
post.messages.yahoo.com
SHARE PRICE in the year 2000
Message 10812182
What suprises can we look forward to on ZICAM?
- Because Zicam is a wonder product that has mass appeal, it
it would not suprise me to see later in the fall coverage by the media (national news, 20/20, investors newspapers, etc).
--- going international sooner than we thought: EVERYONE catches colds. Can anyone think of any other illness that
is as ubiquious as the common cold?
---- NEW ENGLAND JOURNAL OF MEDICINE: here is a quote from
Dr. Howard Epstein, a Pathologist, who is a staunch believer in Zicam and has contributed much to the Due Dilligence for Long Term Investors:
"Most papers that are rejected by the NEJM are done so within 6 weeks. The Zicam initial study has been there for several months and has not been rejected, at least as of the shareholder meeting about 2 weeks ago. What does that mean? It means that there is a decent chance that it will be published, in my opinion. The distribution channels are in place and publicity/distribution/advertising are all set to "gel" together by October. The company has stated that distribution is not a problem. The company has stated that production is not a problem. Some of the early large customers have ordered multiple times without much or any advertising."
THIS IS THE TECHNOLOGY THAT WE ARE INVESTING IN:
zicam.com
Zicam and Gumtech will have an updated WebSite soon.
I began this Thread long ago with the following statement..
HeadLine News for the History of ManKind !
ZICAM eliminates the Common Cold in 1.5 days
What an investment opportunity for the long term.
Regards,
S.W. |
